Filtered By:
Cancer: Cancer
Infectious Disease: Fungal Infections
This page shows you your search results in order of date.
Order by Relevance | Date
Total 53 results found since Jan 2013.
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Recurrent Stroke and Fatal Ruptured Mycotic Aneurysm Caused by Invasive < em > Aspergillus fumigatus < /em > Infection
CONCLUSION: In immunosuppressed patients with neutropenia or using chronic steroids who have concurrent pulmonary and CNS infection, there should be a low threshold to treat empirically for fungal infections prior to confirmation of diagnosis.PMID:33974773
Source: WMJ - May 11, 2021 Category: General Medicine Authors: Istiaq Mian Sam Ives Garry Jean-Louis Andrew Laczniak Source Type: research
